Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151

Issued Date

2026-04-01

Resource Type

Note

ISSN

01495992

eISSN

19355548

DOI

10.2337/dci26-0008

Scopus ID

2-s2.0-105034097011

Pubmed ID

41861128

Journal Title

Diabetes Care

Volume

49

Issue

4

Start Page

75

End Page

76

Rights Holder(s)

SCOPUS

Bibliographic Citation

Diabetes Care Vol.49 No.4 (2026) , 75-76

Suggested Citation

Park C.M., Thanapluetiwong S., Chen X., Oh G., Ko D., Kim D.H. Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151. Diabetes Care Vol.49 No.4 (2026) , 75-76. 76. doi:10.2337/dci26-0008 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116013

Title

Sodium–Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes. Diabetes Care 2026;49:147–151

Author(s)

Park C.M.
 Thanapluetiwong S.
 Chen X.
 Oh G.
 Ko D.
 Kim D.H.

Author's Affiliation

Harvard Medical School
 Beth Israel Deaconess Medical Center
 Ramathibodi Hospital
 Hinda and Arthur Marcus Institute for Aging Research

Corresponding Author(s)

Park C.M.

Other Contributor(s)

Mahidol University

Keyword(s)

Nursing
 Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/116013

Collections

Scopus 2026